DiscoverState of MedtechThis Month in Medtech: Build to Buy, Heartflow IPO, Strategics on the Move
This Month in Medtech: Build to Buy, Heartflow IPO, Strategics on the Move

This Month in Medtech: Build to Buy, Heartflow IPO, Strategics on the Move

Update: 2025-10-08
Share

Description

From billion dollar M&A to FDA greenlights and the next wave of surgical AI, August was packed with major stories in medtech. Omar Khateeb & Nicholas Talamantes break down the month’s biggest moves, from Philips’ restructuring and Medtronic’s AI milestone to emerging neurotech players and investor trends shaping the rest of 2025.


Episode Breakdown:

00:00 Medtech is back: August + September recap

01:05 Omar’s new baby & the team’s European summer break

03:42 The $500 million quarter that proved Medtech’s engine is alive

05:09 Inside LSI’s Hot 25 Startups – how they rank the “hottest” companies

07:32 Why fundraising is still strong despite market headwinds

10:18 How much it really costs to build a surgical robot today

14:44 Thermo Fisher’s $1.5 billion move into organ transplantation

16:13 The sci-fi machine that keeps donor organs alive

18:54 August’s standout deals – AI, cardiology, and diagnostics

21:60 The rise of neuromodulation for hypertension

23:30 Ultrahuman & the $55 million AI cardio boom

25:60 HeartFlow IPO and the new era of cardiovascular investing

27:46 LSI Europe recap – the most promising innovators of 2024

29:04 Dell MedTech and other breakout companies to watch

33:28 Early-stage funding vs late-stage momentum – where money’s really going

36:54 Why investors are tightening on seed rounds but spending big on M&A

40:34 Summer slowdown or market shift? The funding pulse explained

42:09 Why Medtech might be entering its “golden age” of innovation

46:55 Why founders must create content before LSI – visibility equals trust

48:23 The M&A rush continues – Boston Scientific, Edwards, GE Healthcare

50:14 Why these acquisitions prove Medtech’s resilience

55:29 Robotics in stroke care – the next frontier after orthopedics

56:27 Edwards buys Victorious for $497 million – a heart failure game-changer

58:30 September highlights and the next wave of innovators

1:05:31 The $85 million ENT deal that shows minimally invasive is winning

1:07:07 Closing thoughts – Q3 predictions and M&A outlook

1:09:35 Tal Wurzel and the founders who keep building after billion-dollar exits

1:10:26 Outro – subscribe for next month’s State of MedTech


Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.

Subscribe to our Youtube Channel

⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfg⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Subscribe to our LinkedIn Newsletter

⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.stateofmedtechpodcast.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Follow The State of MedTech on

LinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/company/thestateofmedtech⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtech⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

X ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://twitter.com/StateofMedTech⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Follow Omar M. Khateeb on

LinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@omarkhateebofficial⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

X ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://twitter.com/OmarMKhateeb⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb/⁠⁠⁠⁠⁠⁠⁠⁠

#Medtech #Healthcare #AI #Startups #DigitalHealth

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

This Month in Medtech: Build to Buy, Heartflow IPO, Strategics on the Move

This Month in Medtech: Build to Buy, Heartflow IPO, Strategics on the Move

State of Medtech